XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net income (loss) $ 837 $ (6,243)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
Management fee - related party 465 396  
(Income) loss from unconsolidated entities, net (1,002) 453  
Depreciation and amortization 6,024 7,391  
Share-based compensation 19 20  
Straight-line rents (175) (305)  
Amortization of below-market lease intangibles (99) (99)  
Amortization of above-market lease intangibles 43 44  
Amortization of deferred financing costs 312 406  
(Income) loss from investment in affiliated fund, net (653) 933  
Unrealized (gain) loss on real estate-related securities, net (2,154) 322  
Unrealized gain on commercials loans (54) 0  
Unrealized (gain) loss on derivative instruments, net (332) 2,346  
Distributions of earnings from investments in unconsolidated entities 672 795  
Realized loss (gain) on sale of real estate-related securities 1,618 (15)  
Other items 97 221  
Change in assets and liabilities, net of assets and liabilities acquired in acquisitions:      
Decrease (increase) in other assets 341 (261)  
(Decrease) increase in due to affiliates (649) 1,026  
Decrease in accounts payable, accrued expenses and other liabilities (3,744) (2,915)  
Net cash provided by operating activities 1,566 4,515  
Cash flows from investing activities:      
Investments in unconsolidated entities (142) (369)  
Proceeds from unconsolidated entities 646 0  
Investment in affiliated fund 0 (15,000)  
Redemption of investment in affiliated fund 547 0  
Distribution from affiliated fund 653 0  
Origination of commercial loans 0 (13,007)  
Pre-acquisition deposits (1,000) 0  
Capital improvements to real estate (1,302) (685)  
Purchase of real estate-related securities (15,465) (6,249)  
Proceeds from sale of real estate-related securities 8,281 287  
Distributions of capital from investments in unconsolidated entities 1,148 1,413  
Net cash used in investing activities (6,634) (33,610)  
Cash flows from financing activities:      
Proceeds from issuance of common stock 15,030 12,737  
Offering costs paid (38) (86)  
Repurchase of common stock and OP units (13,377) (13,025)  
Subscriptions received in advance 6,853 1,257  
Proceeds from revolving credit facility 0 23,000  
Repayment of revolving credit facility 0 (14,000)  
Borrowings from mortgages payable 0 464  
Payment of deferred financing costs 0 (300)  
Payment of financing obligation (5) 0  
Common stock and INREIT OP unit distributions (3,697) (7,737)  
Preferred stock dividends 0 (2)  
Contributions from non-controlling interests 5,472 28  
Distributions to non-controlling interests (425) (226)  
Net cash provided by financing activities 9,813 2,110  
Net change in cash and cash equivalents and restricted cash 4,745 (26,985)  
Cash and cash equivalents and restricted cash, beginning of period 43,372 45,242 $ 45,242
Cash and cash equivalents and restricted cash, end of period 48,117 18,257 43,372
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:      
Cash and cash equivalents 36,742 12,609 36,046
Restricted cash 11,375 5,648 7,326
Total cash and cash equivalents and restricted cash 48,117 18,257 $ 43,372
Supplemental disclosures:      
Interest paid 5,760 4,824  
Non-cash investing and financing activities:      
Issuance of Class E OP Units to non-controlling interests 0 3,976  
Issuance of Class E shares for payment of management fees 465 399  
Accrued capital expenditures 731 280  
Accrued preferred dividends 2 0  
Distributions payable 3,038 2,894  
Distribution reinvestment 5,279 270  
Accrued offering costs due to affiliates 670 320  
Adjustment to carrying value of redeemable equity instruments 54 (12,324)  
Accrued common stock repurchases $ (5,148) $ 0